ERNA vs TMO · P/E 0.0, rev $582.0K vs P/E 24, rev $44.56B
Eterna Therapeutics Inc (ERNA) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the ERNA and TMO stock pages for the full models.
Not investment advice.